Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 10Carcinoma, Renal Cell 10Urinary Bladder Neoplasms 5Muscle Invasive Bladder Cancer (MIBC) 2Kidney Neoplasms 2Upper Tract Urinary Carcinoma 1Penile Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Muscle-invasive Bladder Urothelial Carcinoma 1Muscle Invasive Bladder Cancer 1Melanoma 1Liver Neoplasms 1High-risk Renal Cell Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma in Situ 1Advanced Urothelial Carcinoma 1

Interventions

valrubicin 3dodecyl maltoside 3Mitomycin 3Gemcitabine 3durvalumab 2Cystoscopy 2toripalimab 1pembrolizumab 1enfortumab vedotin 1cemiplimab 1apaziquone 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Standard of Care 1Oncolytic Virotherapy 1Nivolumab 1Magnetic Resonance Imaging 1Interferons 1Imiquimod 1Histamine Antagonists 1Electrocardiography 1Docetaxel 1Diphenhydramine 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Biopsy 1BCG Vaccine 1Acetaminophen 1ALT-801 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma in Situ × toripalimab × Genitourinary × Clear all
NCT07189793 2025-09-24

OHAI-NMIBC-01

First Affiliated Hospital of Wenzhou Medical University

Phase 2 Not yet recruiting
106 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡